Vaccination granulomas and aluminium allergy: course and prognostic factors.
21 children who had cutaneous granulomas following immunization with a vaccine containing aluminium hydroxide, and who had positive patch tests to aqueous aluminium chloride and/or to a Finn Chamber, were followed for 1 to 8 years. During the period of observation, the symptoms cleared in 5 children, improved in 11, and remained unchanged in 5. The course of the granulomas could not be correlated with sex or atopy, nor with intensity of the initial aluminium patch test. 4 children were patch tested again with aluminium.
Kaaber
K
K
Dermatology Clinic, Herning, Denmark.
Nielsen
A O
AO
Veien
N K
NK
D000293:Adolescent; D000535:Aluminum / Q000009:adverse effects*; D002648:Child; D002675:Child, Preschool; D005260:Female; D005500:Follow-Up Studies; D006099:Granuloma / Q000139:chemically induced* / Q000473:pathology; D006801:Humans; D008297:Male; D010328:Patch Tests; D011379:Prognosis; D012871:Skin Diseases / Q000139:chemically induced* / Q000473:pathology; D014611:Vaccination
D000535:Aluminum